The multiple faces of quercetin in neuroprotection

Expert Opinion on Drug Safety

Volumn 8, Issue 4, 2009, Pages 397-409

  Ossola, Bernardino ^a   Kääriäinen, Tiina M ^b   Männistö, Pekka T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

BBB; In vitro studies; In vivo studies; Neurodegeneration; Quercetin; Quercetin aglycone; Quercetin glycosides; Quercetin metabolites; Quercetin safety; Quercetin toxicity

Indexed keywords

2' GLUTATHIONYLQUERCETIN; 3 HYDROXYMETHYLQUERCETIN; 4' O METHYLQUERCETIN; AGLYCONE; DRUG METABOLITE; GLUCURONIC ACID; ISORHAMNETIN; LIPOSOME; QUERCETIN; QUERCETIN 3 GLUCURONIDE; QUERCETIN 3 METHYL ETHER; QUERCETIN 3 SULFATE; QUERCETIN 7 GLUCURONIDE; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL PROTECTION; CLINICAL TRIAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; LIPOSOMES; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; QUERCETIN;

EID: 67650529189     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330903026944     Document Type: Review

References (111)

1. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007;18:427-442 (Pubitemid 46874924)
2. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585:325-337
3. Bischoff SC. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 2008;11:733-740
4. Dajas F, Rivera-Megret F, Blasina F, et al. Neuroprotection by flavonoids. Braz J Med Biol Res 2003;36:1613-1620
5. Vauzour D, Vafeiadou K, Rodriguez-Mateos A, et al. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 2008;3:115-126
6. Hollman PC, de Vries JH, van Leeuwen SD, et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995;62:1276-1282
7. Manach C, Donovan JL. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 2004;38:771-785 (Pubitemid 39077365)
8. Graefe EU, Wittig J, Mueller S, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 2001;41:492-9 • In human plasma, only quercetin glucuronides, but not quercetin aglycone, was detected.
9. Day AJ, Mellon F, Barron D, et al. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 2001;35:941-952 (Pubitemid 34065683)
10. Youdim KA, Qaiser MZ, Begley DJ, et al. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004;36:592-604 (Pubitemid 38230176)
11. Youdim KA, Dobbie MS, Kuhnle G, et al. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 2003;85:180-192 (Pubitemid 36389708)
12. Kroemer HK, Klotz U. Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 1992;23:292-310
13. Kawai Y, Nishikawa T, Shiba Y, et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008;283:9424-9434
14. Manach C, Morand C, Texier O, et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 1995;125:1911-1922
15. Egert S, Wolffram S, Bosy-Westphal A, et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 2008;138:1615-1621
16. Dajas F, Rivera F, Blasina F, et al. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox Res 2003;5:425-32 • In rats, after single intraperitoneal injection of free quercetin (30 mg/kg), no quercetin was detected in the brain tissue during the period 30 min - 4 h. Quercetin-lecithin preparation augmented the access of quercetin into the brain.
17. de Boer VC, Dihal AA, van der Woude H, et al. Tissue distribution of quercetin in rats and pigs. J Nutr 2005;135:1718-1725 (Pubitemid 40980724)
18. Bieger J, Cermak R, Blank R, et al. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 2008;138:1417-1420
19. Khaled KA, El-Sayed YM, Al-Hadiya BM. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev Ind Pharm 2003;29:397-403 (Pubitemid 36528607)
20. Ferry DR, Smith A, Malkhandi J, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 1996;2:659-668 (Pubitemid 26133468)
21. Arredondo MF, Blasina F, Echeverry C, et al. Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. J Ethnopharmacol 2004;91:13-20 (Pubitemid 38270221)
22. Heo HJ, Lee CY. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J Agric Food Chem 2004;52:7514-7517
23. Sasaki N, Toda T, Kaneko T, et al. Protective effects of flavonoids on the cytotoxicity of linoleic acid hydroperoxide toward rat pheochromocytoma PC12 cells. Chem Biol Interact 2003;145:101-116 (Pubitemid 36246614)
24. Silva JP, Gomes AC, Coutinho OP. Oxidative DNA damage protection and repair by polyphenolic compounds in PC12 cells. Eur J Pharmacol 2008;601:50-60
25. Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 2003;5:287-300 (Pubitemid 37411776)
26. Kim H, Park BS, Lee KG, et al. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 2005;53:8537-8541
27. Sasaki M, Nakamura H, Tsuchiya S, et al. Quercetin-induced PC12 cell death accompanied by caspase-mediated DNA fragmentation. Biol Pharm Bull 2007;30:682-686 (Pubitemid 46570988)
28. Soundararajan R, Wishart AD, Rupasinghe HP, et al. Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis. J Biol Chem 2008;283:2231-2245
29. Bate C, Salmona M, Williams A. Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42. J Neuroinflamm 2004;1:4 (Pubitemid 39130330)
30. Klettner A, Herdegen T. The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response. Br J Pharmacol 2003;138:1004-1012 (Pubitemid 36390658)
31. Donaire V, Niso M, Moran JM, et al. Heat shock proteins protect both MPP(+) and paraquat neurotoxicity. Brain Res Bull 2005;67:509-514 (Pubitemid 41416747)
32. Ossola B, Kääriäinen TM, Raasmaja A, Männistö PT. Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. Toxicology 2008;250:1-8 • Quercetin protective concentrations become toxic after prolonged exposures (> 24 h). Moreover, the toxic effects of quercetin occurred at a concentration only twofold higher than the one that produced the greatest protection. (Pubitemid 352040761)
33. Shirai M, Kawai Y, Yamanishi R, et al. Effect of a conjugated quercetin metabolite, quercetin 3-glucuronide, on lipid hydroperoxide-dependent formation of reactive oxygen species in differentiated PC-12 cells. Free Radic Res 2006;40:1047-1053 (Pubitemid 44480545)
34. Jakubowicz-Gil J, Rzeski W, Zdzisinska B, et al. Different sensitivity of neurons and neuroblastoma cells to quercetin treatment. Acta Neurobiol Exp (Wars) 2008;68:463-476
35. Spencer JP, Rice-Evans C, Williams RJ. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 2003;278:34783-34793 (Pubitemid 37102237)
36. Jakubowicz-Gil J, Rzeski W, Zdzisinska B, et al. Cell death and neuronal arborization upon quercetin treatment in rat neurons. Acta Neurobiol Exp (Wars) 2008;68:139-146 (Pubitemid 351871131)
37. Vafeiadou K, Vauzour D, Rodriguez-Mateos A, et al. Glial metabolism of quercetin reduces its neurotoxic potential. Arch Biochem Biophys 2008;478:195-200
38. Vauzour D, Ravaioli G, Vafeiadou K, et al. Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols. Arch Biochem Biophys 2008;476:145-151
39. Lavoie S, Chen Y, Dalton TP, et al. Curcumin, quercetin and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J Neurochem 2009;108:1410-1422
40. Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006;160:171-177
41. Dok-Go H, Lee KH, Kim HJ, et al. Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten. Brain Res 2003;965:130-136 (Pubitemid 36183694)
42. Ansari MA, Abdul HM, Joshi G, et al. Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. J Nutr Biochem 2008;20:269-275
43. Mercer LD, Kelly BL, Horne MK, Beart PM. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol 2005;69:339-345 (Pubitemid 41556580)
44. Okawara M, Katsuki H, Kurimoto E, et al. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol 2007;73:550-560 (Pubitemid 46038859)
45. Zecca L, Zucca FA, Albertini A, et al. A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology 2006;67:S8-11 (Pubitemid 44568828)
46. McGeer PL, Rogers J, McGeer EG. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 2006;9:271-276 (Pubitemid 44253320)
47. Vafeiadou K, Vauzour D, Spencer JP. Neuroinflammation and its modulation by flavonoids. Endocr Metab Immune Disord Drug Targets 2007;7:211-224
48. Chen JC, Ho FM, Pei-Dawn LEE, et al. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol 2005;521:9-20 (Pubitemid 41427784)
49. Kwon YS, Kim SS, Sohn SJ, et al. Modulation of suppressive activity of lipopolysaccharide-induced nitric oxide production by glycosidation of flavonoids. Arch Pharm Res 2004;27:751-756 (Pubitemid 43086219)
50. Bureau G, Longpre F, Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 2008;86:403-410 • Quercetin aglycone, at concentration as low as 0.1 μM, decreased the toxicity of LPS-activated microglia towards PC12 neurons. (Pubitemid 351196745)
51. Kraus B, Wolff H, Heilmann J, Elstner EF. Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells. Life Sci 2007;81:884-894 (Pubitemid 47381364)
52. Tacconi MT. Neuronal death: is there a role for astrocytes? Neurochem Res 1998;23:759-765
53. Gitika B, Sai Ram M, Sharma SK, et al. Quercetin protects C6 glial cells from oxidative stress induced by tertiary-butylhydroperoxide. Free Radic Res 2006;40:95-102 (Pubitemid 43023790)
54. Chen TJ, Jeng JY, Lin CW, et al. Quercetin inhibition of ROS-dependent and-independent apoptosis in rat glioma C6 cells. Toxicology 2006;223:113-126 (Pubitemid 43728620)
55. Sharma V, Mishra M, Ghosh S, et al. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull 2007;73:55-63 (Pubitemid 46710246)
56. van Meeteren ME, Hendriks JJ, Dijkstra CD, van Tol EA. Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease. Biochem Pharmacol 2004;67:967-975 (Pubitemid 38201642)
57. Santos MR, Rodriguez-Gomez MJ, Justino GC, et al. Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats. Br J Pharmacol 2008;153:1750-1761
58. Spencer JP, Kuhnle GG, Williams RJ, Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 2003;372:173-181 (Pubitemid 36609619)
59. Romero M, Jimenez R, Sanchez M, et al. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 2009;202:58-67
60. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004;36:838-849
61. Shiba Y, Kinoshita T, Chuman H, et al. Flavonoids as substrates and inhibitors of myeloperoxidase: molecular actions of aglycone and metabolites. Chem Res Toxicol 2008;21:1600-1609
62. Cui K, Luo X, Xu K, Ven Murthy MR. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:771-799 (Pubitemid 39195270)
63. Lee HC, Wei YH. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood) 2007;232:592-606 (Pubitemid 46683384)
64. Khlebnikov AI, Schepetkin IA, Domina NG, et al. Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems. Bioorg Med Chem 2007;15:1749-1770 (Pubitemid 46394047)
65. Wang JY, Wen LL, Huang YN, et al. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 2006;12:3521-3533 (Pubitemid 44400489)
66. Rodriguez-Pallares J, Parga JA, Munoz A, et al. Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem 2007;103:145-156 (Pubitemid 47404195)
67. Yuan H, Sarre S, Ebinger G, Michotte Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J Neurosci Methods 2005;144:35-45 (Pubitemid 40546300)
68. Zbarsky V, Datla KP, Parkar S, et al. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005;39:1119-1125 (Pubitemid 41358566)
69. Kääriäinen TM, Piltonen M, Ossola B, et al. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Brain Res 2008;1203:149-159
70. Carvey PM, Zhao CH, Hendey B, et al. 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci 2005;22:1158-1168 (Pubitemid 41395380)
71. Kortekaas R, Leenders KL, van Oostrom JC, et al. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 2005;57:176-179 (Pubitemid 40179854)
72. Schültke E, Kendall E, Kamencic H, et al. Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 2003;20:583-591 (Pubitemid 36807902)
73. Schültke E, Kamencic H, Zhao M, et al. Neuroprotection following fluid percussion brain trauma: a pilot study using quercetin. J Neurotrauma 2005;22:1475-1484 (Pubitemid 43122361)
74. Graham DI, Raghupathi R, Saatman KE, et al. Tissue tears in the white matter after lateral fluid percussion brain injury in the rat: relevance to human brain injury. Acta Neuropathol 2000;99:117-124 (Pubitemid 30093417)
75. Lo EH, Wang X, Cuzner ML. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 2002;69:1-9 (Pubitemid 34734159)
76. Cho JY, Kim IS, Jang YH, et al. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci Lett 2006;404:330-335 (Pubitemid 44131626)
77. Wang YH, Wang WY, Chang CC, et al. Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-oxidative effect and modulation of NF-kappa B activation. J Biomed Sci 2006;13:127-141 (Pubitemid 43162511)
78. Pu F, Mishima K, Irie K, et al. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 2007;104:329-334 (Pubitemid 47378420)
79. Nimmo AJ, Cernak I, Heath DL, et al. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 2004;38:40-47 (Pubitemid 38372964)
80. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-185 (Pubitemid 41043883)
81. Kulik T, Kusano Y, Aronhime S, et al. Regulation of cerebral vasculature in normal and ischemic brain. Neuropharmacology 2008;55:281-288
82. Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 2002;54:271-284 (Pubitemid 34575717)
83. Spencer JP. Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 2008;67:238-252 (Pubitemid 351543406)
84. Kampkötter A, Timpel C, Zurawski RF, et al. Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin. Comp Biochem Physiol B Biochem Mol Biol 2008;149:314-323 (Pubitemid 350300012)
85. Saul N, Pietsch K, Menzel R, Steinberg CE. Quercetin-mediated longevity in Caenorhabditis elegans: is DAF-16 involved? Mech Ageing Dev 2008;129:611-613
86. Kampkötter A, Nkwonkam CG, Zurawski RF, et al. Investigations of protective effects of the flavonoids quercetin and rutin on stress resistance in the model organism Caenorhabditis elegans. Toxicology 2007;234:113-123 (Pubitemid 46517831)
87. Wei H, Li L, Song Q, et al. Behavioural study of the D-galactose induced aging model in C57BL/6J mice. Behav Brain Res 2005;157:245-251 (Pubitemid 40082567)
88. Lu J, Zheng YL, Luo L, et al. Quercetin reverses D-galactose induced neurotoxicity in mouse brain. Behav Brain Res 2006;171:251-260 (Pubitemid 43946498)
89. Nakayama T, Sawada T. Involvement of microtubule integrity in memory impairment caused by colchicine. Pharmacol Biochem Behav 2002;71:119-138 (Pubitemid 34102471)
90. Kumar A, Sehgal N, Kumar P, et al. Protective effect of quercetin against ICV colchicine-induced cognitive dysfunctions and oxidative damage in rats. Phytother Res 2008;22:1563-1569
91. Dutta G, Zhang P, Liu B. The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol 2008;22:453-464
92. Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 1998;780:294-303 (Pubitemid 28082916)
93. Rosi S, McGann K, Hauss-Wegrzyniak B, Wenk GL. The influence of brain inflammation upon neuronal adenosine A2B receptors. J Neurochem 2003;86:220-227 (Pubitemid 36753862)
94. Patil CS, Singh VP, Satyanarayan PS, et al. Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 2003;69:59-67 (Pubitemid 37034425)
95. Pugh CR, Kumagawa K, Fleshner M, et al. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav Immun 1998;12:212-229 (Pubitemid 28520001)
96. Noble F, Rubira E, Boulanouar M, et al. Acute systemic inflammation induces central mitochondrial damage and mnesic deficit in adult Swiss mice. Neurosci Lett 2007;424:106-110 (Pubitemid 47285501)
97. Minami T, Okazaki J, Kawabata A, et al. Penetration of cisplatin into mouse brain by lipopolysaccharide. Toxicology 1998;130:107-113 (Pubitemid 28488579)
98. Wang Q, Luo W, Zheng W, et al. Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. Toxicol Appl Pharmacol 2007;219:33-41 (Pubitemid 46237646)
99. Hu P, Wang M, Chen WH, et al. Quercetin relieves chronic lead exposure-induced impairment of synaptic plasticity in rat dentate gyrus in vivo. Naunyn Schmiedebergs Arch Pharmacol 2008;378:43-51
100. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease - systematic review and meta-analysis. Neurobiol Aging 2009;30:337-352
101. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 2006;1:223-236 (Pubitemid 44244128)
102. Sarkar S, Das N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech Ageing Dev 2006;127:391-397 (Pubitemid 43290543)
103. Ghosh A, Mandal AK, Sarkar S, et al. Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sci 2009;84:75-80
104. Manach C, Scalbert A, Morand C, et al. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747
105. Sullivan M, Follis RH Jr, Hilgartner M. Toxicology of podophyllin. Proc Soc Exp Biol Med 1951;77:269-272
106. Harwood M, Danielewska-Nikiel B, Borzelleca JF, et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007;45:2179-2205 (Pubitemid 47451573)
107. Utesch D, Feige K, Dasenbrock J, et al. Evaluation of the potential in vivo genotoxicity of quercetin. Mutat Res 2008;654:38-44
108. Filipe P, Haigle J, Silva JN, et al. Anti- and pro-oxidant effects of quercetin in copper-induced low density lipoprotein oxidation. Quercetin as an effective antioxidant against pro-oxidant effects of urate. Eur J Biochem 2004;271:1991-1999 (Pubitemid 38657351)
109. Martins Rde P, Braga Hde C, da Silva AP, et al. Synergistic neurotoxicity induced by methylmercury and quercetin in mice. Food Chem Toxicol 2009;47:645-649
110. Franco JL, Braga HC, Stringari J, et al. Mercurial-induced hydrogen peroxide generation in mouse brain mitochondria: protective effects of quercetin. Chem Res Toxicol 2007;20:1919-1926
111. Nicolau M, Dovichi SS, Cuttle G. Pro-inflammatory effect of quercetin by dual blockade of angiotensin converting-enzyme and neutral endopeptidase in vivo. Nutr Neurosci 2003;6:309-316 (Pubitemid 37361913)